HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Persistence of systemic mastocytosis after allogeneic bone marrow transplantation in spite of complete remission of the associated myelodysplastic syndrome.

Abstract
A myelodysplastic syndrome (MDS), type 5 (RAEB-t), and systemic mastocytosis affecting the spleen, the splenic lymph nodes, the bone marrow and the liver were diagnosed in a 38-year-old woman. The clinical course was complicated by splenic vein thromboses and iliac artery embolism. The thrombotic episodes might be secondary to mast cell mediator release. A complete remission of the MDS was obtained by allogeneic bone marrow transplantation, but the mastocytosis persisted. Thus, the possibility that the mast cell originates from a common myeloid precursor cell may be questioned.
AuthorsD Rønnov-Jessen, P Løvgreen Nielsen, T Horn
JournalBone marrow transplantation (Bone Marrow Transplant) Vol. 8 Issue 5 Pg. 413-5 (Nov 1991) ISSN: 0268-3369 [Print] England
PMID1768977 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Bone Marrow Transplantation
  • Embolism (complications)
  • Female
  • Hematopoietic Stem Cells (pathology)
  • Humans
  • Iliac Artery
  • Mast Cells (pathology)
  • Mastocytosis (complications, pathology, surgery)
  • Myelodysplastic Syndromes (complications, pathology, surgery)
  • Splenic Vein
  • Thrombophlebitis (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: